Disposition and metabolism of isoeugenol in the male Fischer 344 rat

被引:33
作者
Badger, DA
Smith, RL
Bao, J
Kuester, RK
Sipes, IG
机构
[1] Univ Arizona, Dept Pharmacol & Toxicol, Tucson, AZ 85721 USA
[2] Univ Arizona, Ctr Toxicol, Tucson, AZ 85721 USA
关键词
isoeugenol; disposition; metabolism; phase II metabolites;
D O I
10.1016/S0278-6915(02)00183-7
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
The primary objective of these studies was to determine the absorption, distribution, metabolism and excretion of isoeugenol following oral and intravenous administration to male Fischer-344 rats. Following a single oral dose of [C-14]isoeugenol (156 mg/kg, 50 muCi/kg), greater than 85% of the administered dose was excreted in the urine predominantly as sulfate or glucuronide metabolites by 72 h. Approximately 10% was recovered in the feces, and less than 0.1% was recovered as CO2 or expired organics. No parent isoeugenol was detected in the blood at any of the time points analyzed. Following iv administration (15.6 mg/kg, 100 muCi/kg), isoeugenol disappeared rapidly from the blood. The t(1/2) was 12 min and the Cl-s was 1.91/min/kg. Excretion characteristics were similar to those of oral administration. The total amount of radioactivity remaining in selected tissues by 72 It was less than 0.25% of the dose following either oral or intravenous administration. Results of these studies show that isoeugenol is rapidly metabolized and is excreted predominantly in the urine as phase 11 conjugates of the parent compound. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1757 / 1765
页数:9
相关论文
共 22 条
[1]   ABSORPTION, METABOLISM AND EXCRETION OF SAFROLE IN RAT AND MAN [J].
BENEDETTI, MS ;
MALNOE, A ;
BROILLET, AL .
TOXICOLOGY, 1977, 7 (01) :69-83
[2]   Skin sensitization to eugenol and isoeugenol in mice: Possible metabolic pathways involving ortho-quinone and quinone methide intermediates [J].
Bertrand, F ;
Basketter, DA ;
Roberts, DW ;
Lepoittevin, JP .
CHEMICAL RESEARCH IN TOXICOLOGY, 1997, 10 (03) :335-343
[3]   DISPOSITION AND EXCRETION OF 2,3,7,8-TETRACHLORODIBENZOFURAN IN THE RAT [J].
BIRNBAUM, LS ;
DECAD, GM ;
MATTHEWS, HB .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1980, 55 (02) :342-352
[4]  
BOBERG EW, 1983, CANCER RES, V43, P5163
[5]   Cytotoxicity and genotoxicity of methyleugenol and related congeners - a mechanism of activation for methyleugenol [J].
Burkey, JL ;
Sauer, JM ;
McQueen, CA ;
Sipes, IG .
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2000, 453 (01) :25-33
[6]  
FENNELL TR, 1984, CANCER RES, V44, P3231
[7]   THE METABOLISM OF EUGENOL IN MAN [J].
FISCHER, IU ;
VONUNRUH, GE ;
DENGLER, HJ .
XENOBIOTICA, 1990, 20 (02) :209-222
[8]  
IARC, 1976, MON EV CARC RISK CHE, V10, P231
[9]  
JIMBO Y, 1983, Journal of Dermatology (Tokyo), V10, P241
[10]  
Klaassen CurtisD., 2001, CASARETT DOULLS TOXI, V6th